Company Profile
IceCure Medical Stock Price, News & Analysis
Company overview
Business overview
IceCure Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, IceCure Medical is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
IceCure Medical makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, IceCure Medical trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
ICCM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
IceCure’s catalysts are ProSense adoption, reimbursement, and any regulatory progress that keeps the cryoablation story alive. The market will care about whether physician adoption keeps broadening.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026
Source: IceCure Medical
- 03
- 04
IceCure Reports 2025 Full Year Financial & Operational Results
Source: IceCure Medical
- 05
IceCure Appoints Meir Peleg as Chief Financial Officer
Source: IceCure Medical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.